Investment Institute
Macroeconomic Research

Framing the ECB’s rate cutting cycle

  • 26 February 2024 (10 min read)

Key points:

  • Market pricing was a poor predictor of actual ECB decisions in the last interest rate hiking cycle. Detailed analysis suggests market expectations more than two to three weeks before an ECB meeting should be viewed with great caution
  • The Orphanides-Wieland rule suggests some upside to our – and the market’s – baseline of a 25-basis-point (bp) ECB rate cut in June. Further out, the Taylor rule highlights that rates could fall by more than the 125bp we predict by end-2025
  • We believe it is worth stepping back from these well-known, yet simple, policy rate rules. The ECB is likely to maintain a more holistic approach, including risk management
  • A cautious approach to using these rules is paramount, reinforced by two key uncertainties – the Eurozone faces multiple large (negative) supply structural changes, which may imply higher price pressures than in the past. Second, fiscal policy in the context of the new Eurozone framework may also be more inflationary than in the past

     
Framing the ECB’s rate cutting cycle
Macroeconomics Macroeconomic Research

Framing the ECB’s rate cutting cycle

  • by François Cabau
  • 26 February 2024 (10 min read)
Investment Institute
2024’s elections around the world: The who’s who and the so what…
Macroeconomics Macroeconomic Research

2024’s elections around the world: The who’s who and the so what…

  • by Irina Topa-Serry, Luis Lopez-Vivas, and others
  • 23 January 2024 (7 min read)
Investment Institute
The key drivers of 10-year US Treasury yields
Macroeconomics Macroeconomic Research

The key drivers of 10-year US Treasury yields

  • by David Page
  • 18 January 2024 (7 min read)
Investment Institute

    Disclaimer

    This website is published by AXA Investment Managers Australia Ltd (ABN 47 107 346 841 AFSL 273320) (“AXA IM Australia”) and is intended only for professional investors, sophisticated investors and wholesale clients as defined in the Corporations Act 2001 (Cth).

    This publication is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Market commentary on the website has been prepared for general informational purposes by the authors, who are part of AXA Investment Managers. This market commentary reflects the views of the authors, and statements in it may differ from the views of others in AXA Investment Managers.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    All investment involves risk , including the loss of capital. The value of investments and the income from them can fluctuate and investors may not get back the amount originally invested.